Immunocidin This is my guess why BNC did not mention cancer in its launch of Immunocidin. I don't know what requirement Canada and U,S. have on veterarian drugs for commercilization. But if it is the same as human drugs, you need to show effecacy through stringent trials. Whereas, for any supplements or herbal formula, as long as you do not claim it is to "cure" something, you don't need to go through these trials.
With the limited cash BNC has, it cannot afford the trials for the animal applications. All it wants now is to generate some sales to raise funds. That's why I think they launch it as an immuno enhencing supplement. Once it is on the market, vet can refer to their publications on the effectiveness of Immunocidin on cancer use. They can choose to use it off label for can cer purposes. Since it is for animal, the threshold for off-label use is also a litle more slack also.
JMHO